The Patent Finder

Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes

Theranos, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,984,932Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes
In force
 · Medium confidence
UsedRemaining
Labrador Diagnostics LLCIn forceMedium confidence
US 10,788,409Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes
In force
 · Medium confidence
Labrador Diagnostics LLCIn forceMedium confidence
US 9,347,867Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes
In force
 · High confidence
Labrador Diagnostics LLCIn forceHigh confidence
US 10,222,310Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes
In force
 · High confidence
Labrador Diagnostics LLCIn forceHigh confidence
US 11,320,355Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes
Lapsed May 3, 2026 on the fee record
High confidence
Labrador Diagnostics LLCLapsed May 3, 2026 on the fee recordHigh confidence
US 10,012,638Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes
Lapsed Jul 3, 2026 on the fee record
Low confidence
Labrador Diagnostics LLCLapsed Jul 3, 2026 on the fee recordLow confidence
US 10,018,549Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes
Lapsed Jul 10, 2026 on the fee record
Medium confidence
Labrador Diagnostics LLCLapsed Jul 10, 2026 on the fee recordMedium confidence
Application 17/028,063Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes
Abandoned
Abandoned Jan 9, 2023
Labrador Diagnostics LLCAbandonedAbandoned Jan 9, 2023
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Theranos, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited